Zurück zum Inhalt

HNO-Heilkunde - Kopf- und Hals-Chirurgie

Transfusionsrisiken und Unabwägbarkeiten

Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome. (öffnet neues Fenster)

Bhide SA, Ahmed M, Rengarajan V, Powell C, Miah A, Newbold K, Nutting CM, Harrington KJ.

Quelle‎: Int J Radiat Oncol Biol Phys 2009;73(2):391-8.

Indiziert‎: PubMed 18692326

DOI‎: 10.1016/j.ijrobp.2008.04.052

https://www.ncbi.nlm.nih.gov/pubmed/18692326 (öffnet neues Fenster)

Does transfusion improve the outcome for HNSCC patients treated with radiotherapy?—results from the randomized DAHANCA 5 and 7 trials. (öffnet neues Fenster)

Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J.

Quelle‎: Acta Oncol 2011;50(7):1006-14.

Indiziert‎: PubMed 21790306

DOI‎: 10.3109/0284186X.2011.592650

https://www.ncbi.nlm.nih.gov/pubmed/21790306 (öffnet neues Fenster)

Transfusion of allogenic leukocyte-depleted packed red blood cells is associated with postoperative morbidity in patients undergoing oral and oropharyngeal cancer surgery. (öffnet neues Fenster)

Perisanidis C, Dettke M, Papadogeorgakis N, Schoppmann A, Mittlböck M, Kyzas PA, Ewers R, Seemann R.

Quelle‎: Oral Oncol 2012;48(4):372-8.

Indiziert‎: PubMed 22182932

DOI‎: 10.1016/j.oraloncology.2011.11.020

https://www.ncbi.nlm.nih.gov/pubmed/22182932 (öffnet neues Fenster)